News

Cadence Partners with VEDP and BRCC for Job Starter Program

Cadence and several other local Shenandoah Valley, Virginia-based manufacturers are teaming up with the Virginia Economic Development Partnership (VEDP) and Blue Ridge Community College for their new Job Starter training program.  Job Starter is a paid training program that allows potential job candidates the opportunity to receive training and meet local employers during a 3-week period.  Ultimately, this program is intended to help members of the community land a career in the advanced manufacturing industry with the employer of their choice.

“It was a great experience to be part of the team of local employers that helped develop this program with Blue Ridge Community College and VEDP,” said Rachel Brown, Human Resources Manager at Cadence’s Virginia facility.  “I believe Job Starter will be an excellent resource for Shenandoah Valley residents that are interested in having a career in advanced manufacturing.”

Job Starter begins October 25 and runs through November 15.  Careers in the program include, but are not limited to, production associates, machine operators, and manufacturing apprentices.  Other local companies participating in the program are Berry Global, Daikin Applied, Dynamic Aviation, Innovative Refrigeration Systems, McKee Foods, and Provides US.

To learn more about Job Starter or to register for this inaugural program, please visit: https://www2.cadenceinc.com/BRCCjobstarter.

Recent News

02/22/2024

Protected: Don’t Miss These Spring Talent Events

There is no excerpt because this is a protected post.

02/21/2024

SRI selected as spoke for both ARPA-H Customer Experience Hub and Investor Catalyst Hub

SRI has been selected by the Advanced Research Projects Agency for Health (ARPA-H) to serve as a spoke within the Customer Experience Hub (CX Hub) and the Investor Catalyst Hub (IC Hub), as part of ARPANET-H, a nationwide health innovation network launched in September 2023. “Hundreds of organizations have been selected to join each network.

02/21/2024

ReAlta Life Sciences Announces Dosing of First Patient in Phase 2 Trial of RLS-0071 for Acute Exacerbations of Chronic Obstructive Pulmonary Disease

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life-threatening diseases, announced enrollment of the first patient in a Phase 2 clinical trial evaluating the safety and efficacy of RLS-0071, an investigational new drug based on ReAlta’s novel EPICC peptide